Lauren Sabella
2011
In 2011, Lauren Sabella earned a total compensation of $1.1M as Executive Vice President, Commercial Development at Acorda Therapeutics.
Compensation breakdown
| Bonus | $119,552 |
|---|---|
| Option Awards | $378,374 |
| Salary | $327,333 |
| Stock Awards | $227,505 |
| Other | $7,350 |
| Total | $1,060,114 |
Sabella received $378.4K in option awards, accounting for 36% of the total pay in 2011.
Sabella also received $119.6K in bonus, $327.3K in salary, $227.5K in stock awards and $7.4K in other compensation.
Rankings
In 2011, Lauren Sabella's compensation ranked 5,433rd out of 10,747 executives tracked by ExecPay. In other words, Sabella earned more than 49.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,433 out of 10,747 | 49th |
Division Manufacturing | 1,967 out of 3,960 | 50th |
Major group Chemicals And Allied Products | 431 out of 1,033 | 58th |
Industry group Drugs | 271 out of 781 | 65th |
Industry Biological Products, Except Diagnostic Substances | 46 out of 157 | 71st |
Source: SEC filing on April 26, 2012.
Sabella's colleagues
We found five more compensation records of executives who worked with Lauren Sabella at Acorda Therapeutics in 2011.
2011
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2011
Jane Wasman
Acorda Therapeutics
General Counsel
2011
Andrew Blight
Acorda Therapeutics
Chief Scientific Officer
2011
Thomas Wessel
Acorda Therapeutics
Chief Medical Officer
2011
David Lawrence
Acorda Therapeutics
Chief Financial Officer
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019